Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,918 | 549 | 98.0% |
| Education | $164.51 | 6 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $993.59 | 76 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $923.03 | 52 | $0 (2024) |
| Novo Nordisk Inc | $426.70 | 57 | $0 (2024) |
| Amgen Inc. | $411.50 | 25 | $0 (2024) |
| PFIZER INC. | $387.23 | 23 | $0 (2024) |
| Abbott Laboratories | $386.11 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $379.37 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $372.75 | 19 | $0 (2024) |
| Allergan, Inc. | $316.28 | 23 | $0 (2020) |
| Merck Sharp & Dohme LLC | $308.58 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $843.76 | 48 | ABBVIE INC. ($157.33) |
| 2023 | $771.03 | 48 | AbbVie Inc. ($275.90) |
| 2022 | $958.22 | 62 | ABBVIE INC. ($179.89) |
| 2021 | $1,520 | 94 | AbbVie Inc. ($342.78) |
| 2020 | $1,040 | 66 | AstraZeneca Pharmaceuticals LP ($208.18) |
| 2019 | $892.51 | 61 | AstraZeneca Pharmaceuticals LP ($196.62) |
| 2018 | $934.07 | 75 | Allergan Inc. ($181.73) |
| 2017 | $1,123 | 101 | AstraZeneca Pharmaceuticals LP ($177.80) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.88 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/29/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $31.50 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: PAIN | ||||||
| 08/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Cranial Orthotic | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Neuroscience | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Endocrinology | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,136 | 1,562 | $107,351 | $51,077 |
| 2022 | 34 | 1,299 | 2,992 | $161,537 | $81,418 |
| 2021 | 33 | 1,382 | 2,856 | $146,258 | $81,579 |
| 2020 | 34 | 1,491 | 3,029 | $149,882 | $72,583 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 253 | $46,046 | $18,434 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 139 | $18,487 | $8,068 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $11,286 | $7,966 | 70.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $4,875 | $3,956 | 81.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 126 | 213 | $1,491 | $1,447 | 97.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 23 | 27 | $2,700 | $1,203 | 44.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $1,280 | $1,144 | 89.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 82 | 98 | $2,646 | $995.93 | 37.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 68 | 69 | $2,277 | $905.28 | 39.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 89 | 117 | $1,638 | $883.84 | 54.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 48 | 52 | $2,184 | $855.92 | 39.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 51 | 68 | $1,632 | $647.36 | 39.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 38 | 43 | $1,677 | $635.54 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $512.00 | $469.28 | 91.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $480.00 | $410.62 | 85.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 13 | 13 | $949.00 | $352.23 | 37.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 16 | 22 | $660.00 | $342.95 | 52.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 25 | 41 | $820.00 | $324.31 | 39.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 16 | 23 | $828.00 | $307.28 | 37.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 12 | 17 | $782.00 | $306.34 | 39.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 30 | $1,110 | $267.32 | 24.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 44 | 74 | $592.00 | $230.14 | 38.9% |
| 83550 | Iron binding capacity | Office | 2023 | 16 | 22 | $484.00 | $188.54 | 39.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 15 | 19 | $399.00 | $161.12 | 40.4% |
| 87088 | Bacterial urine culture | Office | 2023 | 15 | 19 | $342.00 | $150.67 | 44.1% |
About Dr. Christopher Davis, DO
Dr. Christopher Davis, DO is a Family Medicine healthcare provider based in Layton, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1346565561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Davis, DO has received a total of $8,082 in payments from pharmaceutical and medical device companies, with $843.76 received in 2024. These payments were reported across 555 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($7,918).
As a Medicare-enrolled provider, Davis has provided services to 5,308 Medicare beneficiaries, totaling 10,439 services with total Medicare billing of $286,657. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Layton, UT
- Active Since 03/30/2010
- Last Updated 01/18/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346565561
Products in Payments
- VRAYLAR (Drug) $852.41
- FARXIGA (Drug) $441.59
- XARELTO (Drug) $283.69
- NURTEC ODT (Drug) $281.37
- UBRELVY (Drug) $257.72
- TRADJENTA (Drug) $222.79
- FREESTYLE LIBRE 2 (Device) $197.10
- TRELEGY ELLIPTA (Drug) $194.52
- SYMBICORT (Drug) $177.29
- TOUJEO (Drug) $166.74
- TRULICITY (Drug) $164.79
- Vascepa (Drug) $161.07
- MYRBETRIQ (Drug) $156.71
- Aimovig (Biological) $149.10
- BREZTRI (Drug) $129.94
- JANUVIA (Drug) $111.31
- Ozempic (Drug) $102.91
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $102.71
- FREESTYLE LIBRE 3 (Device) $93.47
- Victoza (Drug) $86.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Layton
Courtney Nelson, Do, DO
Family Medicine — Payments: $159,170
Mr. Kevin Gardner, Md, MD
Family Medicine — Payments: $15,101
Layne Barker, Md, MD
Family Medicine — Payments: $14,292
Mr. Jeffery Degrauw, Md, MD
Family Medicine — Payments: $13,347
Dr. Johnnie Cook, Md, MD
Family Medicine — Payments: $9,806
Marc Anderson, Md, MD
Family Medicine — Payments: $9,609